Kite Pharma Inc (KITE) - Financial and Strategic SWOT Analysis Review

  • ID: 4281564
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Kite Pharma Inc
1 of 5


  • Fate Therapeutics Inc
  • Kura Oncology Inc
  • RegenxBio Inc
  • MORE
Kite Pharma Inc (Kite Pharma) is a bio-pharmaceutical company that discovers and develops cancer immunotherapy products. The company concentrates on chimeric antigen receptors (CAR) and T cell receptors (TCR) engineered cell therapies. It offers KTE-C19 in a critical trial for the treatment of refractory, aggressive non-Hodgkin Lymphoma (NHL). Kite Pharma also provides early research and product development services. The company developed engineered autologous T-cell therapy (eACT) technology platform that allows to strengthen patient’s own immune system to target and kill cancer cells. It works in collaboration with various institutes and companies. The company has operational presence in the Netherlands and the US. Kite Pharma is headquartered in Santa Monica, California, the US.

Kite Pharma Inc Key Recent Developments

Jul 23, 2018: Kite partners with Gadeta to develop new cancer therapies
Jul 09, 2018: Kite Names Michael Amoroso As Senior Vice President And Head Of Worldwide Commercial, Cell Therapy
May 15, 2018: Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy Pipeline
Jan 11, 2018: Adimab Initiates Update on Clinical Progression of Partner Programs
Aug 08, 2017: Kite Reports Second Quarter 2017 Financial Results

This comprehensive SWOT profile of Kite Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by the Author to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the Author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Kite Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 5


  • Fate Therapeutics Inc
  • Kura Oncology Inc
  • RegenxBio Inc
  • MORE
Section 1 - About the Company

Kite Pharma Inc - Key Information
Kite Pharma Inc - Overview
Kite Pharma Inc - Key Employees
Kite Pharma Inc - Key Employee Biographies
Kite Pharma Inc - Key Operational Heads
Kite Pharma Inc - Major Products and Services
Kite Pharma Inc - History
Kite Pharma Inc - Company Statement
Kite Pharma Inc - Locations And Subsidiaries
Kite Pharma Inc - Key Manufacturing facilities Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Kite Pharma Inc - Business Description
Kite Pharma Inc - Corporate Strategy
Kite Pharma Inc - SWOT Analysis
SWOT Analysis - Overview
Kite Pharma Inc - Strengths
Kite Pharma Inc - Weaknesses
Kite Pharma Inc - Opportunities
Kite Pharma Inc - Threats
Kite Pharma Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Kite Pharma Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About Us
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Kite Pharma Inc, Key Information
Kite Pharma Inc, Key Ratios
Kite Pharma Inc, Share Data
Kite Pharma Inc, Major Products and Services
Kite Pharma Inc, History
Kite Pharma Inc, Key Employees
Kite Pharma Inc, Key Employee Biographies
Kite Pharma Inc, Key Operational Heads
Kite Pharma Inc, Other Locations
Kite Pharma Inc, Subsidiaries
Kite Pharma Inc, Key Manufacturing facilities
Kite Pharma Inc, Key Competitors
Kite Pharma Inc, SWOT Analysis
Kite Pharma Inc, Ratios based on current share price
Kite Pharma Inc, Annual Ratios
Kite Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Kite Pharma Inc, Performance Chart
Kite Pharma Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • RegenxBio Inc
  • Kura Oncology Inc
  • Fate Therapeutics Inc
  • Actinium Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown